Not all osmolality is created equal.
作者信息
Fenton T R
出版信息
Arch Dis Child Fetal Neonatal Ed. 2006 May;91(3):F234.
Abstract
摘要
相似文献
1
Not all osmolality is created equal.并非所有的渗透压都是一样的。
Arch Dis Child Fetal Neonatal Ed. 2006 May;91(3):F234.
2
Increased osmolality of breast milk with therapeutic additives.添加治疗性添加剂后母乳渗透压升高。
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F514-7. doi: 10.1136/adc.2003.037192.
3
Effect of Fortification and Additives on Breast Milk Osmolality.强化与添加剂对母乳渗透压的影响。
Indian Pediatr. 2016 Feb;53(2):167-9.
4
Comparison between homologous human milk supplements and a commercial supplement for very low birth weight infants.同源人乳补充剂与一种专为极低出生体重婴儿设计的商业补充剂的比较。
J Pediatr (Rio J). 2012 Mar-Apr;88(2):119-24. doi: 10.2223/JPED.2166. Epub 2012 Mar 8.
5
Effect of fortification on the osmolality of human milk.强化对人乳渗透压的影响。
Arch Dis Child Fetal Neonatal Ed. 1999 Sep;81(2):F141-3. doi: 10.1136/fn.81.2.f141.
6
Medications That Increase Osmolality and Compromise the Safety of Enteral Feeding in Preterm Infants.增加渗透压并危及早产儿肠内喂养安全性的药物。
Neonatology. 2017;111(4):309-316. doi: 10.1159/000454667. Epub 2016 Dec 29.
7
8
Osmolality of a fortified human preterm milk: The effect of fortifier dosage, gestational age, lactation stage, and hospital practices.强化人早产儿母乳的渗透压：强化剂剂量、胎龄、泌乳阶段及医院操作的影响
Arch Pediatr. 2018 Oct;25(7):411-415. doi: 10.1016/j.arcped.2018.08.006. Epub 2018 Sep 18.
9
Milk osmolality: does it matter?奶渗透压：这有影响吗？
Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F166-9. doi: 10.1136/adc.2011.300492. Epub 2011 Sep 19.
10
Effect of fortifiers on the osmolality of preterm human milk.强化剂对早产母乳渗透压的影响。
Paediatr Int Child Health. 2019 Nov;39(4):275-278. doi: 10.1080/20469047.2019.1575537. Epub 2019 Feb 11.
引用本文的文献
1
What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?对于患有动脉导管未闭的早产儿，开始肠内给予布洛芬所需的最低喂养量是多少？
Pediatr Rep. 2022 Jul 24;14(3):333-337. doi: 10.3390/pediatric14030040.
本文引用的文献
1
Increased osmolality of breast milk with therapeutic additives.添加治疗性添加剂后母乳渗透压升高。
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F514-7. doi: 10.1136/adc.2003.037192.
2
Oral gastrografin in neonates: a note of caution.新生儿口服泛影葡胺：一则警示
Int J Clin Pract. 1999 Oct-Nov;53(7):565.
3
Hypovolemic shock and intestinal ischemia: a preventable complication of incomplete formula labeling.
J Pediatr. 1993 Jan;122(1):103-4. doi: 10.1016/s0022-3476(05)83500-0.
4
Hypertonic formula resulting from added oral medications.
Am J Dis Child. 1982 Oct;136(10):931-3. doi: 10.1001/archpedi.1982.03970460061013.
5
Current concepts. Serum osmolality. Uses and limitations.当前概念。血清渗透压。用途及局限性。
N Engl J Med. 1984 Jan 12;310(2):102-5. doi: 10.1056/NEJM198401123100207.
6
Functional and histological injury to intestinal mucosa produced by hypertonicity.高渗性对肠黏膜造成的功能和组织学损伤。
Am J Physiol. 1968 May;214(5):1090-5. doi: 10.1152/ajplegacy.1968.214.5.1090.
7
Response of the small intestine to the application of a hypertonic solution.小肠对高渗溶液应用的反应。
Am J Pathol. 1973 Dec;73(3):747-64.
8
The effects of water-soluble contrast media on luminal distension and blood flow in closed loops of small bowel in minipigs.水溶性造影剂对小型猪小肠闭合肠袢管腔扩张及血流的影响
Scand J Gastroenterol. 1988 Oct;23(8):991-9. doi: 10.3109/00365528809090159.
9
Osmolality--limits of physical tests.渗透压摩尔浓度——物理检验的限度
Dev Pharmacol Ther. 1988;11(5):313-6. doi: 10.1159/000457707.
10
Acute lethality after enteral administration of contrast media in anaesthetized rats with intestinal ischaemia.
Acta Radiol. 1989 Mar-Apr;30(2):213-6.
Zotero 插件